Igen International is Biotechnology in United States that focus on enzyme drug discovery business. Founded in 1982. They cover business area such as Provider, biological detection system, cellular diagnostic, antibiotic resistance testing, clinical chemistry testing, viral enzyme drug discovery, viral load testing, HIV, food testing, water testing, immunochemistry, cancer diagnostic, RNA, DNA analysis service.
1982
( 42 years old in 2024 )
Enzyme Drug Discovery
-
16020 Industrial Drive
Gaithersburg, MD 20877
United States
Private
Providerbiological detection systemcellular diagnosticantibiotic resistance testingclinical chemistry testingviral enzyme drug discoveryviral load testingHIVfood testingwater testingimmunochemistrycancer diagnosticRNADNA analysis service
* We use standard office opening hours in near Igen International's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Igen International is Biotechnology business from United States that founded in 1982 (42 years old in 2024), Igen International business is focusing on Enzyme Drug Discovery.
Igen International headquarter office and corporate office address is located in 16020 Industrial Drive Gaithersburg, MD 20877 United States.
Igen International was founded in United States.
In 2024, Igen International is currently focus on enzyme drug discovery sector.
Above is snippet of Google Trends for "enzyme drug discovery" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Igen International, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
